About one in 9,000 females in Australia are diagnosed with Rett Syndrome at birth. In the US, about 15,000 girls…
Stamping the letters ‘FDA’ on a Company announcement is a surefire way to flag investors’ interest. Today it was clinical…
There’s been a small bump in the road in Cyclopharm’s (ASX: CYC) plans to secure regulatory approval for Technegas™, their…
Mental health medtech company Medibio (ASX: MEB) has continued its accelerated plans towards FDA approvals under new management with the…
As the world battles the coronavirus pandemic, G Medical (ASX: GMV) has secured authorisation from the Food and Drug Administration…
Australian medtech company Cyclopharm (ASX: CYC) is set to add the United States to the list of 59 countries which…